- Home
- UPB vs RC Comparison
UPB vs RC Comparison
Compare UPB & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- RC
- Stock Information
- Founded
- UPB 2021
- RC 2007
- Country
- UPB United States
- RC United States
- Employees
- UPB N/A
- RC N/A
- Industry
- UPB
- RC Real Estate Investment Trusts
- Sector
- UPB
- RC Real Estate
- Exchange
- UPB NYSE
- RC Nasdaq
- Market Cap
- UPB 1.1B
- RC 1.2B
- IPO Year
- UPB 2024
- RC N/A
- Fundamental
- Price
- UPB $16.21
- RC $7.26
- Analyst Decision
- UPB Strong Buy
- RC Hold
- Analyst Count
- UPB 4
- RC 10
- Target Price
- UPB $56.50
- RC $29.25
- AVG Volume (30 Days)
- UPB 462.3K
- RC 2.0M
- Earning Date
- UPB 02-14-2025
- RC 11-07-2024
- Dividend Yield
- UPB N/A
- RC 13.77%
- EPS Growth
- UPB N/A
- RC N/A
- EPS
- UPB N/A
- RC N/A
- Revenue
- UPB $2,207,000.00
- RC $140,359,000.00
- Revenue This Year
- UPB N/A
- RC N/A
- Revenue Next Year
- UPB N/A
- RC $13.62
- P/E Ratio
- UPB N/A
- RC N/A
- Revenue Growth
- UPB 82.10
- RC N/A
- 52 Week Low
- UPB $14.97
- RC $6.65
- 52 Week High
- UPB $29.46
- RC $11.11
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- RC 48.69
- Support Level
- UPB N/A
- RC $7.17
- Resistance Level
- UPB N/A
- RC $7.64
- Average True Range (ATR)
- UPB 0.00
- RC 0.22
- MACD
- UPB 0.00
- RC -0.03
- Stochastic Oscillator
- UPB 0.00
- RC 40.63
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.